Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
Study title | Condition | Phase | Location |
---|---|---|---|
Ribociclib (LEE011) Rollover Study for Continued Access |
Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies | Phase2 | Taiwan United States |
Kesimpta (Ofatumumab) Pregnancy Registry |
Multiple Sclerosis, Pregnancy | United States | |
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). |
Systemic Lupus Erythematosus | Phase3 | United States Spain Thailand Czechia Poland Malaysia Germany China Australia Japan Canada Hungary Taiwan View All |
Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection |
Melanoma | China | |
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas |
Metastatic Uveal Melanoma | Phase1, Phase2 | United States Germany Netherlands Spain Australia France Switzerland View All |
A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis |
Relapsing Multiple Sclerosis | Germany | |
A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia |
Warm Autoimmune Hemolytic Anemia (wAIHA) | Phase3 | United States Israel Japan Italy Thailand Spain United Kingdom France Romania Argentina Australia China Hungary Germany India Malaysia Singapore Taiwan View All |
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan |
Prostate Cancer | Phase2 | Japan |
Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer |
Non-small Cell Lung Cancer | Phase1 | United States Spain Japan Germany Switzerland Korea, Republic of View All |
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases |
Myeloid Diseases | Phase1 | United States Italy Germany France Hong Kong Spain Singapore View All |
Pagination
- ‹‹ Previous page
- 1
- …
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- …
- 18
- ›› Next page